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after adjusting for the effects of sex and age at the 
time of the bombing (ATB), reporting an excess 
relative risk of death due to cerebrovascular dis-
ease of 0.12 (90% confidence interval: 0.02–0.22) 
per Sv of radiation dose22). Shimizu et al also ob-
served a non-significant (p = 0.23) correlation with 
radiation dose, reporting an excess relative risk 
per Gy of 36%, 9%, 15% and 5% for ages < 10, 10-
19, 20-39, and ≥ 4025). These studies examined the 
relationship between the initial radiation dose 
(initial dose) and the mortality risk. Atomic bomb 
radiation exposure can be divided into two types: 
direct exposure (gamma-ray as well as immediate 
and delayed neutron radiations) from the initial 
explosion and indirect exposure from residual ra-
diation comprising neutron activated radiation in 
Arteriosclerotic cardiovascular disease is now 
the cause of death of approximately one in three 
Japanese people. In the 1960s, cerebrovascular 
disease was the leading cause of death in Japan, 
but it is now the third leading cause, with a dra-
matically decreasing tendency since the 1970s7). 
With approximately 70 years having passed since 
the atomic bombs were dropped, almost all atomic 
bomb survivors (hibakusha) now belong to the 
generation in which the onset of cardiovascular 
disease is common, and the effects of radiation on 
cardiovascular disease have been well studied. 
However, we have not yet clearly grasped the im-
pact of exposure to radiation from atomic bombs 
on cerebrovascular disease. Preston et al observed 
a significant correlation with initial radiation dose 
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ABSTRACT
Several studies have been conducted on cerebrovascular disease mortality in Atomic bomb 
survivors. Previous studies have investigated the relationship between mortality and initial 
radiation dose after adjusting for the effects of sex and age at the time of the bombing (ATB), and 
detected a weak (but statistically significant) dose-response relationship was detected. The objective 
of the present study was to examine whether the sex- and age ATB-specific cerebrovascular disease 
mortality among Hiroshima atomic bomb survivors can be explained by the initial radiation dose. At 
Hiroshima University, a cohort study has been conducted with Hiroshima Atomic Bomb Survivors 
(ABS) since 1970. We selected 30,378 subjects from the ABS who were exposed at 3.5 km or less 
from the hypocenter and still alive on January 1, 1970. These subjects were followed up until 
December 31, 2010. The cohort data were stratified with respect to sex and age ATB into 10-year age 
groups. For each stratum, using Cox regression, we performed survival analyses of the risk of 
cerebrovascular mortality using the initial radiation dose and the exposure distance (the ground 
distance between the exposure location and the hypocenter) as explanatory variables. The results 
indicated that the risks to females exposed at 10 to 19 years old were highly dependent on the initial 
radiation dose (hazard ratio: 1.51, p < 0.001), while the risks to males were not. There might exist 
some radiation exposure effects limited to women who were in their teens at the time of exposure. 
However, the background mechanisms remain unclear, necessitating further study.
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initial radiation dose.
SUBJECTS AND METHODS
For the present study we used the database of 
Atomic Bomb Survivors (ABS) that has been man-
aged by the Research Institute for Radiation Biology 
and Medicine (RIRBM) of Hiroshima University14). 
The ABS differs from the Life Span Study (LSS) 
of the Radiation Effects Research Foundation 
(RERF), which that is based on subjects throughout 
Japan, in that the subjects in the ABS are restrict-
ed to Atomic bomb survivors residing in Hiroshima 
Prefecture. From the ABS, we chose for analysis 
30,378 subjects (11,683 males and 18,695 females) 
who satisfied the following conditions: (i) alive and 
recognized as an atomic bomb survivor as of Janu-
ary 1, 1970 (the start of the observation period) 
and (ii) information available on the coordinates of 
their location at the time of atomic bomb exposure 
(abbreviated as ‘‘location at exposure’’). The dis-
tance from the hypocenter to the location at expo-
sure (abbreviated as “exposure distance”) was 
within 3.5 km. These subjects were followed until 
December 31, 2010 for death from cerebrovascular 
disease (number of deaths: 1,006 among males, 
1,945 among females).  The death information in-
cluding the cause of death was obtained from the 
Vital Statistics Death Schedules which are based 
soil and other materials as well as fallout from the 
nuclear explosion. The initial dose is determined by 
the ground distance from the hypocenter to the 
victim’s location at the time of exposure (exposure 
distance) and shielding conditions assessed from 
information provided by exposed persons, such as 
being in buildings or other structures at the time 
of the bombing. If all of this information is avail-
able, the individual direct, initial radiation dose 
may be estimated. However, it is almost impossible 
to estimate the individual amount of exposure 
from residual radiation, because of uncertain or 
lacking information on individual movements and 
activities just after the bombing.
The impact of residual radiation as a health 
hazard has traditionally been assumed to be neg-
ligible12,26). However, it is becoming clear that the 
increase in several health risks related to hibaku-
sha cannot be explained by the effect of initial 
dose alone24). Tonda et al28) showed that the geo-
graphical distribution of the risk of solid cancer 
mortality among Hiroshima hibakusha is not cir-
cular asymmetry around the hypocenter. Recently, 
Kerr et al13) reported that the health risk among 
atomic bomb survivors in Hiroshima and Nagasa-
ki of residual radiation from neutron-activated 
radionuclides in the airburst’s dust stem and ped-
estal and in uplifted soil might be not negligible. 
Tonda et al27) suggested the impact of indirect ex-
posure as a factor in the increased leukemia risk 
for those who entered Hiroshima City on 6 August 
1945. Otani et al17) reported that the mortality 
risk for malignant neoplasms (excluding leukemia) 
was significantly higher for those who entered Hi-
roshima City on 6 August 1945. The results of 
both of those studies apply as well to hibakusha 
who were directly exposed age ATB since they 
were also exposed to residual radiation. Ohtaki et 
al16) reported that the mortality rate for solid can-
cers among hibakusha is influenced not only by 
the initial dose of radiation but also by indirect 
exposure. 
In observational epidemiologic studies, con-
founding is one of the major limitations. Shimizu 
et al25) indicated that smoking, alcohol intake, edu-
cation, occupation, obesity, and diabetes had had 
almost no impact on radiation risk estimates for 
stroke. In our study, it was impossible to analyze 
the data by adjusting confounding factors such as 
high blood pressure, a smoking habit, etc. For even 
if the association between radiation risk and cere-
brovascular disease is actually due to some con-
founding factor so that radiation risk is not causally 
related to cerebrovascular disease, screening for 
radiation risk can nevertheless be useful because 
it permits us to identify people who are at high 
risk for the disease. The objective of the present 
study was to examine whether the sex- and age 
ATB-specific cerebrovascular disease mortality 
among hibakusha can be explained solely by the 
Table 1.1.  Number of subjects, events, and censored cases 
by sex and age at time of exposure (ATB)
(Males)
age ATB 
(yrs)
number of 
subjects
number of 
events
number of 
censored 
cases†
number of 
surviving 
cases††
[0, 10) 3472 46 555 2871
[10, 20) 2877 121 1179 1577
[20, 30) 1139 105 812 222
[30, 40) 1684 253 1321 110
[40, 50) 1725 318 1322 85
[50, 60) 703 146 526 31
[60, 70) 78 16 61 1
[70, 80) 5 1 4 0
total 11683 1006 5780 4897
(Females)
age ATB 
(yrs)
number of 
subjects
number of 
events
number of 
censored 
cases†
number of 
surviving 
cases††
[0, 10) 3332 23 1129 2180
[10, 20) 3701 104 1291 2306
[20, 30) 3708 279 2077 1352
[30, 40) 3701 557 2954 190
[40, 50) 2943 638 2301 4
[50, 60) 1112 294 818 0
[60, 70) 188 49 139 0
[70, 80) 10 1 9 0
total 18695 1945 10718 6032
 † Number of persons who emigrated out of Hiroshima 
prefecture or who died from other causes of death.
 ††Number of persons still alive at 31 Dec 2010.
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it was shown that the dose estimates of the ABS 
were close to those of the LSS among overlapping 
subjects.  However, it has not yet been investigated 
on the official death certificates. Subjects who 
were alive at the end of follow-up, migrated outside 
Hiroshima Prefecture, or died from other causes 
were treated as censored (5,780 males and 10,718 
females).  Numbers of subjects categorized by age 
ATB and exposure distance are shown in Table 1.1 
and 1.2 for each sex, respectively. From these ta-
bles, it is indicated that about 40% of the subjects 
were under 20 years-old at the bombing in this co-
hort data, and that approximately 5% of the sub-
jects were bombed near the hypocenter with the 
distance less than 1.2 km. 
1. Radiation dosimetry
To access the effect of initial radiation dose on 
the human body (unit of measurement: Sv), we 
used the red bone marrow absorbed neutron and 
gamma doses (unit of measurement: Gy) estimated 
using the Atomic Bomb Survivor 1993 Dose (which 
is referred to as ABS93D)8). The radiation dose 
calculated with ABS93D is based on the initial ra-
diation exposure only, as is DS86, and ignores the 
effects of residual radiation20-22). The extent of 
overlap between survivors in the ABS and the 
LSS was examined by Hayakawa et al6) in which 
Fig. 1. Scatterplot of initial radiation dose versus 
exposure distance
Table 1.2. Number of subjects, events, and censored 
cases by sex and exposure distance
(Males)
distance 
(km)
number of 
subjects
number of 
events 
(CVD)
number of 
censored 
cases†
number of 
surviving 
cases††
[0.0, 0.8) 1 0 1 0
[0.8, 1.0) 159 14 103 42
[1.0, 1.2) 454 52 257 145
[1.2, 1.4) 967 100 498 369
[1.4, 1.6) 1223 90 610 523
[1.6, 1.8) 994 94 506 394
[1.8, 2.0) 705 66 373 266
[2.0, 2.5) 1083 97 549 437
[2.5, 3.0) 3959 310 1895 1754
[3.0, 3.5) 2138 183 988 967
total 11683 1006 5780 4897
(Females)
distance 
(km)
number of 
subjects
number of 
events 
(CVD)
number of 
censored 
cases†
number of 
surviving 
cases††
[0.0, 0.8) 5 0 2 3
[0.8, 1.0) 275 27 200 48
[1.0, 1.2) 909 100 582 227
[1.2, 1.4) 1806 210 1089 507
[1.4, 1.6) 2380 271 1425 684
[1.6, 1.8) 1768 182 1048 538
[1.8, 2.0) 1156 128 650 378
[2.0, 2.5) 1354 136 759 459
[2.5, 3.0) 5526 543 2987 1996
[3.0, 3.5) 3516 348 1976 1192
total 18695 1945 10718 6032
†Number of persons who emigrated out of Hiroshima 
prefecture or who died from other causes of death.
††Number of persons still alive at 31 Dec 2010.
Table 1.3. Number of subjects, events, and censored 
cases by sex and dose categories
(Males)
dose(Sv) number of subjects
number of 
events 
(CVD)
number of 
censored 
cases†
number of 
surviving 
cases††
[0.00, 0.01) 6931 561 3305 3065
[0.01, 0.05) 682 75 385 222
[0.05, 0.1) 731 65 358 308
[0.1, 0.2) 972 84 503 385
[0.2, 0.4) 1027 84 532 411
[0.4, 0.6) 399 37 186 176
[0.6, 0.8) 250 27 116 107
[0.8, 1.0) 190 28 112 50
[1.0, 1.5) 193 16 102 75
[1.5, 2.0) 111 10 62 39
[2.0, 6.0) 197 19 119 59
total 11683 1006 5780 4897
(Females)
dose(Sv) number of subjects
number of 
events 
(CVD)
number of 
censored 
cases†
number of 
surviving 
cases††
[0.00, 0.01) 9960 975 5466 3519
[0.01, 0.05) 1170 134 684 352
[0.05, 0.1) 1339 139 783 417
[0.1, 0.2) 1833 212 1094 527
[0.2, 0.4) 1941 227 1174 540
[0.4, 0.6) 771 85 444 242
[0.6, 0.8) 448 44 266 138
[0.8, 1.0) 397 48 264 85
[1.0, 1.5) 341 31 216 94
[1.5, 2.0) 173 20 101 52
[2.0, 6.0) 322 30 226 66
total 18695 1945 10718 6032
†Number of persons who emigrated out of Hiroshima 
prefecture or who died from other causes of death.
††Number of persons still alive at 31 Dec 2010.
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where μ is a parameter denoting the threshold of 
exposure-distance effect. Thus the distance-func-
tion model is expressed by:
The cohort data were classified by sex and by age 
ATB into eight strata—[0, 10), [10, 20), [20, 30), 
and [30, 80) groups for each sex—and a time-de-
pendent Cox regression analysis2,3) was applied to 
each stratum with a hazard model using initial 
dose D or exposure-distance function D*, where 
the estimated regression coefficient βa expresses 
the stratum-averaged effect of initial radiation 
dose or exposure distance and the estimated pa-
rameter μ is a location parameter in the-exposure-
distance function. To fit the model, we adopted the 
optimize function23) in the R software (version 
3.0.0). Since it is noted that the model with the 
minimum AIC has the best goodness of prediction, 
we used AIC to select the optimal model from the 
three models (the initial-dose model, the distance-
function model and the null model with neither 
initial dose nor distance function as explanatory 
variables). 
The null model is expressed by:
Significance tests in all cases were at the 5% level 
with a two-tailed test.
RESULTS
Kaplan-Meier survival curves by initial dose for 
men and women are shown in Figs. 2.1 and 2.2, 
respectively, and those by exposure distance are 
shown in Figs. 2.3 and 2.4. For men, the log-rank 
test indicated no significant difference between 
the low-dose (less than 100 mSv) and high-dose 
(1.0 Sv or more) exposure groups in any age-ATB 
stratum (Fig. 2.1). Similarly, no significant differ-
ences were observed in survival rates between the 
short-distance (less than 1.2 km) and long-dis-
tance (2.0 km or more) groups in any age-ATB 
stratum (Fig. 2.3). For women whose age ATB was 
between 10 and 19, the survival rate of the high-
dose (1.0 Sv or more) group was significantly lower 
than that of the low-dose (less than 100 mSv) 
group (Fig. 2.2). Further, for women whose age 
ATB was either between 10 and 19 or 50 or more, 
the survival rate in the short-distance (less than 
1.2 km) group was significantly lower than that in 
the long-distance (2.0 km or more) group (Fig. 2.4). 
In all other strata of age ATB, no significant dif-
ferences in survival rates were observed. 
Tables 2.1 and 2.2 display estimated values and 
significance of the regression coefficient β. In all 
how ABS93D corresponds with DS02. Table 1.3 
shows the sex-specific numbers of subjects catego-
rized by initial dose. About 70% of the subjects be-
long to the low-doses (less than 100 mSv) exposure 
group and approximately 4% belong to the high-
doses (1.0 Sv or more) exposure group. Figure 1 
shows a scatterplot of subjects’ initial radiation 
dose versus exposure distance with the fitted 
curves based on a power function of exposure dis-
tance.  It is noted that the initial radiation dose 
for the subjects can be roughly fitted by an inverse 
of 5th power function of exposure-distance.
2. Kaplan-Meier Curves
Assuming that there would be sex differences in 
the risk of cardiovascular disease10) and a depen-
dency on age ATB among hibakusha, we stratified 
the cohort data by sex and age ATB, and calculated 
the probability of not dying from cerebrovascular 
diseases (abbreviated simply as “survival probabili-
ty”) by initial dose and exposure distance using 
the Kaplan-Meier method11). Figures 2.1~2.4 show 
the survival rate for each sex- and age ATB-specif-
ic stratum. For these strata, we compared the sur-
vival curves of the cohorts exposed to low doses 
(less than 100 mSv) and high doses (1.0 Sv or 
more), and the survival curves of the cohorts ex-
posed at short distances (less than 1.2 km) and 
long distances (2.0 km or more) using the log-rank 
test.
3. Cox Regression analysis
To quantify the effect of initial dose and expo-
sure distance in detail, we conducted a survival 
analysis using a mathematical model as defined 
below. Based on the epidemiological observation 
that the mortality risk from cerebrovascular dis-
ease rises exponentially with increasing age30), the 
hazard at attained age t, which incorporates the 
effect of the initial radiation dose D at age a (the 
initial-dose model), is expressed by:
where βa is the regression coefficient for the im-
pact of the initial dose among hibakusha who were 
age a at the time of exposure, while g (t,y) is a log-
arithmic function of calendar year (y) and age (t) 
for the cerebrovascular disease mortality rate in 
all of Japan during the period 1970 to 2010, which 
is specified approximately by a quintic polynomial 
equation of t and y. The parameter δ denotes a co-
efficient expressing the logarithmic value of the 
background relative mortality risk of cerebrovascu-
lar disease for the Hiroshima hibakusha compared 
with the whole of Japan. Further, to investigate the 
impact of exposure distance, the following func-
tion of exposure distance r (in km, where the value 
for r = 2 km or more was assumed to be 0) was 
used as an alternative variable in place of initial 
radiation dose D,
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Fig. 2.1. Kaplan-Meier survival curves by initial radiation dose for males stratified by age ATB in 10-year age group. 
The p-value indicates the statistical significance of the difference between the low-dose group (< 0.1 Sv) and the high-
dose group ( >1.0 Sv).
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Fig. 2.2. Kaplan-Meier survival curves by initial radiation dose for females stratified by age ATB in 10-year age group. 
The p-value indicates the statistical significance of the difference between the low-dose group (< 0.1 Sv) and the high-
dose group ( >1.0 Sv).
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Fig. 2.3. Kaplan-Meier survival curves by exposure-distance for males stratified by age ATB in 10-year age group. The 
p-value indicates the statistical significance of the difference between the short-distance group (<1.2 km) and the long-
distance group (>2.0 km).
Fig. 2.4. Kaplan-Meier survival curves by exposure-distance for females stratified by age ATB in 10-year age group. 
The p-value indicates the statistical significance of the difference between the short-distance group (<1.2 km) and 
long-distance group (>2.0 km).
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fluencing risk of mortality from cerebrovascular 
disease. It is also assumed that many hibakusha 
inhaled fine radioactive particulate material after 
the explosion, even if they were inside large build-
ings or in a basement at the time of the explosion, 
and that behavioral patterns just after the bomb-
ing were largely dependent on sex and age ATB, 
which leads to the deduction that “dose” due to re-
sidual radiation must depend on sex and age ATB. 
Due to the reasons described above, we stratified 
the hibakusha’s cohort data according to sex and 
age ATB, and analyzed the effect of exposure to 
radiation, separately. Residual radiation comprises 
neutron activated radiation in soil and other mate-
rials as well as fallout from the nuclear explosion. 
Radioactive contaminants were generated in the 
neighborhood of the hypocenter and were dis-
persed with the bomb blast. Because the dose from 
residual radiation exposure should not be greatly 
influenced by the degree of shelter from direct radi-
ation at the time of the explosion, the present study 
also utilized an analysis based on distance from 
the hypocenter as an alternate index of exposure. 
The exposure-distance model is thought to be a 
good alternative to the initial-dose model, in 
which effects of shielding from direct Atomic bomb 
radiation were not taken into account. In the expo-
sure-distance model, we assumed that the effect of 
an exposure-distance of 2.0 km or more was 0. 
In our Cox regression analyses, since the follow-
up period for this study covers 41 years from 1970 
models for men, no significant contribution was 
detected for either initial dose or exposure dis-
tance. In women, a significantly high contribution 
was detected for the influence of initial dose (haz-
ard ratio: 1.51, p < 0.001) only if their age ATB 
was between 10 and 19.
Table 3 shows estimated values of the parameter 
μ of the distance function model. Table 4 shows 
AIC1) for the initial dose model, the exposure-dis-
tance model, and the null model, applied to each 
stratum of age ATB. In men whose age ATB was 
under 10, the distance-function model had the 
minimum AIC. In women whose age ATB was be-
tween 10 and 19, the initial-dose model had the 
minimum AIC. The null model had the minimum 
AIC in other age-ATB strata.
DISCUSSION
The principal risk factors for cerebrovascular 
disease include aging and arteriosclerosis15). The 
female sex hormone estrogen works to inhibit ar-
teriosclerosis by suppressing increases in LDL 
cholesterol and raising HDL cholesterol level19,29). 
Accordingly, during the period of life with plenti-
ful secretion of female sex hormone, women have a 
significantly lower risk of cardiovascular disease 
than men10). Thus, sex is a confounding factor in-
Table 2.1. Sex- and age ATB-specific estimated coefficients 
(β) of the dose effect
(Males)
age ATB coef. s.e. 95%lower 95%upper p-value
[ 0, 10) -0.513 0.558 -1.606 0.579 0.36
[10, 20) 0.033 0.212 -0.382 0.449 0.87
[20, 30) 0.224 0.173 -0.114 0.562 0.19
[30, 80) 0.107 0.743 -0.038 0.252 0.15
(Females)
age ATB coef. s.e. 95%lower 95%upper p-value
[ 0, 10) 0.330 0.324 -0.305 0.964 0.31
[10, 20) 0.410** 0.115 0.185 0.636 <0.001
[20, 30) -0.115 0.142 -0.394 0.163 0.42
[30, 80) 0.031 0.058 -0.083 0.145 0.60
 **: p < 0.01
Table 2.2. Sex- and age ATB-specific estimated coef-
ficients (β) of the distance effect
(Males)
age ATB coef. s.e. 95%lower 95%upper p-value
[ 0, 10) -29.343 63.225 -153.262 94.577 0.64
[10, 20) 0.275 0.322 -0.357 0.906 0.39
[20, 30) 0.437 0.361 -0.270 1.144 0.23
[30, 80) 0.263 0.158 -0.047 0.572 0.10
(Females)
age ATB coef. s.e. 95%lower 95%upper p-value
[ 0, 10) 1.139 0.708 -0.248 2.526 0.11
[10, 20) 1.071** 0.279 0.524 1.617 < 0.001
[20, 30) -0.320 0.209 -0.730 0.089 0.12
[30, 80) 0.086 0.098 -0.106 0.278 0.38
 **: p < 0.01
Table 3. Sex- and age ATB-specific estimated parameter 
(μ) of the exposure-distance function
age ATB Males Females
[ 0, 10) 1.24 1.19
[10, 20) 2.00 1.23
[20, 30) 1.67 2.00
[30, 80) 1.43 1.68
Table 4. AIC of candidate models and differences in AIC 
between initial-dose and other models
(Males)
age ATB dose(a) dist(b) null(c) Δdist† Δnull††
[ 0, 10) 680.3 678.9 679.5 -1.4 -0.8
[10, 20) 1755.5 1756.8 1753.5 1.3 -2.0
[20, 30) 1315.8 1317.9 1315.2 2.1 -0.6
[30, 80) 9921.6 9922.9 9921.6 1.3 -0.1
(Females)
age ATB dose(a) dist(b) null(c) Δdist† Δnull††
[ 0, 10) 354.2 355.3 353.0 1.1 -1.2
[10, 20) 1624.8 1625.1 1631.2 0.3 6.4
[20, 30) 4222.9 4223.2 4221.6 0.3 -1.3
[30, 80) 23467.2 23468.7 23465.4 1.5 -1.8
†(b)–(a): The difference in AIC between the initial-dose 
model and distance-function model
††(c)–(a): The difference in AIC between initial-dose model 
and null model 
※ Initial radiation dose model has one, distance-function 
model has two, null model has no unknown parameters.
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commenced in 1970, 25 years after exposure to 
the Atomic bomb, it is likely that many deaths oc-
curred prior to the start of the cohort study not 
only from the effects of the explosion but also due 
to acute radiation syndrome. Therefore, people 
with a relatively high risk of death from radiation-
related cerebrovascular disease might have been 
selectively excluded. As a result, we may have un-
derestimated the excess risk for the effect of expo-
sure to the atomic bomb.
Our study had the same limitation as LSS by 
Ozasa et al18) in RERF due to analyses without ad-
justing for the possible effects of confounding fac-
tors, since such information was not available in 
the large cohort studies. For even if some con-
founding factors mislead the effect of radiation 
risk to cerebrovascular disease mortality, the re-
sult of this study must be a clue toward clarifying 
how radiation risk affects cerebrovascular disease. 
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